297 related articles for article (PubMed ID: 25019065)
1. Treatments for biomedical abnormalities associated with autism spectrum disorder.
Frye RE; Rossignol DA
Front Pediatr; 2014; 2():66. PubMed ID: 25019065
[TBL] [Abstract][Full Text] [Related]
2. Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
Frye RE; Delatorre R; Taylor H; Slattery J; Melnyk S; Chowdhury N; James SJ
Transl Psychiatry; 2013 Jun; 3(6):e273. PubMed ID: 23778583
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder.
Frye RE; Rossignol DA; Scahill L; McDougle CJ; Huberman H; Quadros EV
Semin Pediatr Neurol; 2020 Oct; 35():100835. PubMed ID: 32892962
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.
Rossignol DA; Frye RE
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834493
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
Rossignol DA; Frye RE
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442428
[TBL] [Abstract][Full Text] [Related]
6. Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.
Frye RE; Rossignol DA
Clin Med Insights Pediatr; 2016; 10():43-56. PubMed ID: 27330338
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Treatment for Metabolic Disorders Associated with Autism:Reanalysis of Three Clinical Trials.
Delhey LM; Tippett M; Rose S; Bennuri SC; Slattery JC; Melnyk S; James SJ; Frye RE
Front Neurosci; 2018; 12():19. PubMed ID: 29483858
[TBL] [Abstract][Full Text] [Related]
8. The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment.
Frye RE; Lane A; Worner A; Werner BA; McCarty PJ; Scheck AC; Collins HL; Adelman SJ; Quadros EV; Rossignol DA
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556254
[TBL] [Abstract][Full Text] [Related]
9. The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.
Rossignol DA; Frye RE
Front Pediatr; 2014; 2():87. PubMed ID: 25202686
[TBL] [Abstract][Full Text] [Related]
10. Folate metabolism abnormalities in autism: potential biomarkers.
Frye RE; Slattery JC; Quadros EV
Biomark Med; 2017 Aug; 11(8):687-699. PubMed ID: 28770615
[TBL] [Abstract][Full Text] [Related]
11. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.
Frye RE; Rossignol D; Casanova MF; Brown GL; Martin V; Edelson S; Coben R; Lewine J; Slattery JC; Lau C; Hardy P; Fatemi SH; Folsom TD; Macfabe D; Adams JB
Front Public Health; 2013 Sep; 1():31. PubMed ID: 24350200
[TBL] [Abstract][Full Text] [Related]
12. Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups.
Frye RE; Delhey L; Slattery J; Tippett M; Wynne R; Rose S; Kahler SG; Bennuri SC; Melnyk S; Sequeira JM; Quadros E
Front Neurosci; 2016; 10():80. PubMed ID: 27013943
[TBL] [Abstract][Full Text] [Related]
13. Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder.
Frye RE; McCarty PJ; Werner BA; Scheck AC; Collins HL; Adelman SJ; Rossignol DA; Quadros EV
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248763
[TBL] [Abstract][Full Text] [Related]
14. Novel and emerging treatments for autism spectrum disorders: a systematic review.
Rossignol DA
Ann Clin Psychiatry; 2009; 21(4):213-36. PubMed ID: 19917212
[TBL] [Abstract][Full Text] [Related]
15. Targeted Biomedical Treatment for Autism Spectrum Disorders.
Pacheva I; Ivanov I
Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Three Clinical Trial Treatments for Autism Spectrum Disorder Through Multivariate Analysis of Changes in Metabolic Profiles and Adaptive Behavior.
Vargason T; Kruger U; Roth E; Delhey LM; Tippett M; Rose S; Bennuri SC; Slattery JC; Melnyk S; James SJ; Frye RE; Hahn J
Front Cell Neurosci; 2018; 12():503. PubMed ID: 30618645
[TBL] [Abstract][Full Text] [Related]
17. Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder.
Thom RP; Pereira JA; Sipsock D; McDougle CJ
Curr Psychiatry Rep; 2021 Oct; 23(12):79. PubMed ID: 34643815
[TBL] [Abstract][Full Text] [Related]
18. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Frye RE; Melnyk S; Macfabe DF
Transl Psychiatry; 2013 Jan; 3(1):e220. PubMed ID: 23340503
[TBL] [Abstract][Full Text] [Related]
19. Metabolic pathology of autism in relation to redox metabolism.
Frye RE; James SJ
Biomark Med; 2014; 8(3):321-30. PubMed ID: 24712422
[TBL] [Abstract][Full Text] [Related]
20. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.
Frye RE; Slattery J; Delhey L; Furgerson B; Strickland T; Tippett M; Sailey A; Wynne R; Rose S; Melnyk S; Jill James S; Sequeira JM; Quadros EV
Mol Psychiatry; 2018 Feb; 23(2):247-256. PubMed ID: 27752075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
